Elevation of procalcitonin level in patients with pulmonary tuberculosis and in medical staff with close patient contact

被引:16
作者
Kandemir, Ö
Uluba, B
Polat, G
Sezer, C
Çamdeviren, H
Kaya, A
机构
[1] Mersin Univ, Tip Fak Hastanesi, Klin Mikrobiyol Veinfeksiyon Hastaliklari AD, Dept Clin Microbiol & Infect Dis, TR-33079 Mersin, Turkey
[2] Mersin Univ, Fac Med, Dept Chest Dis, TR-33079 Mersin, Turkey
[3] Mersin Univ, Fac Med, Dept Biochem, TR-33079 Mersin, Turkey
[4] Mersin Univ, Fac Med, Dept Biostat, TR-33079 Mersin, Turkey
[5] Ankara Ataturk Chest Dis & Surg Ctr, Ankara, Turkey
关键词
pulmonary tuberculosis; procalcitonin; medical staff;
D O I
10.1016/S0188-4409(03)00050-X
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Several studies have shown that serum procalcitonin levels increase conspicuously in acute and systemic inflammatory diseases. However, there is insufficient information concerning its activity in chronic infectious diseases such as tuberculosis. In this study, we aimed to assess serum level of procalcitonin in patients with active pulmonary tuberculosis and in medical staff at high risk due to close patient contact (high-risk staff). Methods. For this purpose, 30 patients (6 female, 24 male) and 20 staff (8 female, 12 male) were evaluated. Twenty eight healthy blood donors (9 female, 19 male) made up the control group. Results. Serum procalcitonin level in patients with tuberculosis was 0.76 +/- 0.20 ng/mL. Procalcitonin levels in active tuberculosis patients and staff were not significantly different (p = 0.381); however, differences between active tuberculosis patients and control group were significant (p <0.001). In addition, serum procalcitonin levels were also different in staff and control groups (p <0.001). Conclusions. This study showed that procalcitonin levels increased both in patients with pulmonary tuberculosis and in the staff. This result considered that procalcitonin could be a good indicator of inflammation in patients with chronic diseases and in persons exposed to long-lasting infections. (C) 2003 IMSS. Published by Elsevier Science Inc.
引用
收藏
页码:311 / 314
页数:4
相关论文
共 19 条
[1]  
ADEMA GJ, 1992, J BIOL CHEM, V267, P7943
[2]  
Al-Nawas B, 1996, Eur J Med Res, V1, P331
[3]   Procalcitonin in patients with and without immunosuppression and sepsis [J].
AlNawas, B ;
Shah, PM .
INFECTION, 1996, 24 (06) :434-436
[4]   Occupational transmission of Mycobacterium tuberculosis to health care workers in a university hospital in Lima, Peru [J].
Alonso-Echanove, J ;
Granich, RM ;
Laszlo, A ;
Chu, G ;
Borja, N ;
Blas, R ;
Olortegui, A ;
Binkin, NJ ;
Jarvis, WR .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (05) :589-596
[5]   HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[6]   DELAYED-TYPE HYPERSENSITIVITY AND CELL-MEDIATED-IMMUNITY IN THE PATHOGENESIS OF TUBERCULOSIS [J].
DANNENBERG, AM .
IMMUNOLOGY TODAY, 1991, 12 (07) :228-233
[7]   Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia [J].
deWerra, I ;
Jaccard, C ;
Corradin, SB ;
Chiolero, R ;
Yersin, B ;
Gallati, H ;
Assicot, M ;
Bohuon, C ;
Baumgartner, JD ;
Glauser, MP ;
Heumann, D .
CRITICAL CARE MEDICINE, 1997, 25 (04) :607-613
[8]   Procalcitonin, a marker of bacterial infection [J].
Gendrel, D ;
Bohuon, C .
INFECTION, 1997, 25 (03) :133-134
[9]  
GRAMM HJ, 1995, CHIR GASTROENTERO S2, V11, P51
[10]   Procalcitonin - A new indicator of the systemic response to severe infections [J].
Karzai, W ;
Oberhoffer, M ;
MeierHellmann, A ;
Reinhart, K .
INFECTION, 1997, 25 (06) :329-334